Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
J Agric Food Chem ; 64(2): 394-402, 2016 Jan 20.
Artigo em Inglês | MEDLINE | ID: mdl-26751159

RESUMO

Advances in biotechnology continue to drive the development of a wide range of insect-protected, herbicide-tolerant, stress-tolerant, and nutritionally enhanced genetically modified (GM) crops, yet societal and public policy considerations may slow their commercialization. Such restrictions may disproportionately affect developing countries, as well as smaller entrepreneurial and public sector initiatives. The 2014 IUPAC International Congress of Pesticide Chemistry (San Francisco, CA, USA; August 2014) included a symposium on "Challenges Associated with Global Adoption of Agricultural Biotechnology" to review current obstacles in promoting GM crops. Challenges identified by symposium presenters included (i) poor public understanding of GM technology and the need for enhanced communication strategies, (ii) nonharmonized and prescriptive regulatory requirements, and (iii) limited experience with regulations and product development within some public sector programs. The need for holistic resistance management programs to enable the most effective use of insect-protected crops was also a point of emphasis. This paper provides details on the symposium discussion and provides background information that can be used in support of further adoption of beneficial GM crops. Overall, it emphasizes that global adoption of modern agricultural biotechnology has not only provided benefits to growers and consumers but has great potential to provide solutions to an increasing global population and diminishing agricultural land. This potential will be realized by continued scientific innovation, harmonized regulatory systems, and broader communication of the benefits of the high-yielding, disease-resistant, and nutritionally enhanced crops attainable through modern biotechnology.


Assuntos
Produtos Agrícolas/normas , Alimentos Geneticamente Modificados/normas , Plantas Geneticamente Modificadas/química , Setor Público , Produtos Agrícolas/química , Produtos Agrícolas/genética , Inocuidade dos Alimentos , Humanos , Plantas Geneticamente Modificadas/genética , Setor Público/legislação & jurisprudência
3.
J Agric Food Chem ; 61(35): 8333-9, 2013 Sep 04.
Artigo em Inglês | MEDLINE | ID: mdl-23899040

RESUMO

The importance of food composition in safety assessments of genetically modified (GM) food is described for cassava ( Manihot esculenta Crantz) that naturally contains significantly high levels of cyanogenic glycoside (CG) toxicants in roots and leaves. The assessment of the safety of GM cassava would logically require comparison with a non-GM crop with a proven "history of safe use". This study investigates this statement for cassava. A non-GM comparator that qualifies would be a processed product with CG level below the approved maximum level in food and that also satisfies a "worst case" of total dietary consumption. Although acute and chronic toxicity benchmark CG values for humans have been determined, intake data are scarce. Therefore, the non-GM cassava comparator is defined on the "best available knowledge". We consider nutritional values for cassava and conclude that CG residues in food should be a priority topic for research.


Assuntos
Inocuidade dos Alimentos/métodos , Manihot/química , Manihot/genética , Plantas Geneticamente Modificadas/química , Produtos Agrícolas/química , Produtos Agrícolas/genética , Meio Ambiente , Manipulação de Alimentos/métodos , Variação Genética , Glicosídeos/toxicidade , Humanos , Valor Nutritivo , Folhas de Planta/química , Raízes de Plantas/química , Medição de Risco
4.
Transgenic Res ; 20(5): 1055-71, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21197601

RESUMO

In many countries there are increasing calls for the benefits of genetically modified organisms (GMOs) to be considered as well as the risks, and for a risk-benefit analysis to form an integral part of GMO regulatory frameworks. This trend represents a shift away from the strict emphasis on risks, which is encapsulated in the Precautionary Principle that forms the basis for the Cartagena Protocol on Biosafety, and which is reflected in the national legislation of many countries. The introduction of risk-benefit analysis of GMOs would be facilitated if clear methodologies were available to support the analysis. Up to now, methodologies for risk-benefit analysis that would be applicable to the introduction of GMOs have not been well defined. This paper describes a relatively simple semi-quantitative methodology that could be easily applied as a decision support tool, giving particular consideration to the needs of regulators in developing countries where there are limited resources and experience. The application of the methodology is demonstrated using the release of an insect resistant maize variety in South Africa as a case study. The applicability of the method in the South African regulatory system is also discussed, as an example of what might be involved in introducing changes into an existing regulatory process.


Assuntos
Animais Geneticamente Modificados/fisiologia , Medição de Risco/métodos , Agricultura/estatística & dados numéricos , Animais , Animais Geneticamente Modificados/genética , Animais Geneticamente Modificados/metabolismo , Bacillus thuringiensis/genética , Bacillus thuringiensis/metabolismo , Estudos de Avaliação como Assunto , Humanos , África do Sul
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...